OUR MARKET: OSTEOPOROSIS DETECTION AND FOLLOW UP


Osteoporosis is a disease characterized by low bone mass and micro architectural deterioration of bone tissue, leading to increased bone fragility and a greater potential for frature risk.



This silent disease is becoming an increasing concern because it is so prevalent.  According to the IOF (International Osteoporosis Foundation), osteoporosis affects approximately 75 million people in Europe, the United States and Japan, and this number is expected to double within 50 years.

Medilink's mission is to provide innovative solutions that help bone specialisits to monitor people at risk for osteoporosis as well as to diagnose and successfully treat those who suffer from it.


OUR COMPANY


Located in Montpellier in the south of France, MEDILINK is an economic driving force in its region. Medilink offers a complete range of DXA and ultrasound equipment for osteoporosis screening and follow-up.

Our know-how based on 17 years experience in the medical imaging field, has enabled us to design a full range of devices to meet market requirements. Our product range is based on a close collaboration with our user’s network, and our developments are informed through market research. The new MEDIX range combines technology, performance, versatility and a smart investment.